Search

2024 NOV 6 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Researchers detail new data in giant cell arteritis. According to news reporting out of the [...]

Byline: Sarah Kaplan, Laura Reiley, Christopher Rowland, Rebecca Tan and Karen Weintraub It's been eight long and lonely weeks since the coronavirus pandemic shut down most of America: eight weeks [...]

Byline: Elizabeth Weise, USA TODAY SAN FRANCISCO - Doctors and scientists are working furiously to find effective treatments for the illness caused by the new coronavirus but are cautioning the [...]

- At a young age, Randi learned the importance of selfá-advocacy and honest conversations in the face of health struggles. Like most kids, she enjoyed sports and being active. When [...]

As interleukin receptor (IL) inhibitors, the monoclonal antibody drug class has come to revolutionize fields of inflammatory disease care, though the utility and resourcing of such promising agents is yet [...]

TARRYTOWN: Regeneron Pharmaceuticals, Inc. has issued the following news release: Homozygous familial hypercholesterolemia affects approximately 1,300 patients in the U.S., the vast majority of whom are unable to reach target [...]

As many as 4,000 severely ailing coronavirus patients in New York are being treated with the anti-malarial drug hydroxychloroquine, state well being officers say. President Trump has touted hydroxychloroquine as [...]

(GlobeNewswire) - Reportlinker.com announces the release of the report 'COVID-19 Vaccine And Therapeutics Pipeline Analysis 2020' - https://www.reportlinker.com/p05933754/?utm_source=GNW The COVID19 vaccine and therapeutics pipeline analysis market covered in this report [...]

(GlobeNewswire) - Reportlinker.com announces the release of the report 'Coronavirus (COVID-19) Current Therapy Global Market Report 2020: COVID 19 Growth and Change' - https://www.reportlinker.com/p05933757/?utm_source=GNW The global COVID-19 current therapy market [...]

New York, July 21, Jul 21, 2020 (GLOBE NEWSWIRE via COMTEX) -- Reportlinker.com announces the release of the report 'COVID-19 Vaccine And Therapeutics Pipeline Analysis 2020' - https://www.reportlinker.com/p05933754/?utm_source=GNW The COVID19 [...]

New York, July 21, Jul 21, 2020 (GLOBE NEWSWIRE via COMTEX) -- Reportlinker.com announces the release of the report 'Coronavirus (COVID-19) Current Therapy Global Market Report 2020: COVID 19 Growth [...]

Hard on the heels of Regeneron moving its COVID-19 antibody cocktail into late-stage testing, the US government has agreed a deal to ramp up manufacturing and claim the first doses [...]

Hopes that already-approved drugs targeting IL-6 could be repurposed to treat COVID-19 have been undermined by disappointing results from the first large-scale trial of Sanofi and Regenerons Kevzara. The two [...]

TARRYTOWN: Regeneron Pharmaceuticals, Inc. has issued the following press release: First publication to demonstrate benefit of combining CD28 costimulatory bispecifics with anti-PD-1 therapy, overcoming resistance to anti-PD-1 monotherapy and endowing [...]

(GLOBE NEWSWIRE via COMTEX) -- Sanofi's virtual R&D Day event to highlight capabilities, platforms, and expertise in disease pathways to deliver potentially transformative treatments to patients - R&D strategy driving [...]

Sanofi Chief Executive Officer Paul Hudson, Global Head of R&D John Reed, M.D., Ph.D., and members of the R&D and commercial leadership teams will provide an update on Sanofis approach [...]

Introduction The most common question that comes to mind when dealing with biologics and biosimilars is, 'Is there a difference between a generic drug and a biologic/biosimilar?' Beginning with the [...]

London: UK Parliament has issued the following written answer: Answered by: Jo Churchill Answered on: 29 May 2020 Treatments for COVID-19 are currently being trialled in both large Phase III [...]

M2 PRESSWIRE-May 6, 2020-: Sanofi and Regeneron reveal preliminary results of their going COVID-19 vaccine trial (C)1994-2020 M2 COMMUNICATIONS RDATE:05052020 Sanofi and Regeneron Pharmaceuticals, Inc. recently published the preliminary results [...]

Regeneron and Sanofi will amend their phase 3 trial evaluating sarilumab (Kevzara) in hospitalized patients with severe or critical illness caused by coronavirus disease 2019 (COVID-19) to include only critical [...]

TARRYTOWN: Regeneron Pharmaceuticals, Inc. has issued the following news release: Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced the preliminary results from the Phase 2 portion of an ongoing [...]

Paris: Sanofi has issued the following news release: Sanofi and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the preliminary results from the Phase 2 portion of an ongoing Phase 2/3 [...]

The fast-growing list of possible treatments for the novel coronavirus includes an unlikely candidate: famotidine, the active compound in the over-the-counter heartburn drug Pepcid. On 7 April, the first COVID-19 [...]

Sanofi and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the preliminary results from the Phase 2 portion of an ongoing Phase 2/3 trial evaluating Kevzara (sarilumab), an interleukin-6 (IL-6) receptor [...]

Byline: M. Corey Goldman To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: https://www.thestreet.com/investing/regeneron-sanofi-rheumatoid-arthritis-drug-treating-coronavirus-patients A drug co-produced by Regeneron (REGN) and Sanofi (SNY) [...]

(GLOBE NEWSWIRE via COMTEX) -- Sanofi and Regeneron provide update on U.S. Phase 2/3 adaptive-designed trial in hospitalized COVID-19 patients - Independent Data Monitoring Committee recommended continuing ongoing Phase 3 [...]

Famotidine, which is better known to Americans as a cheap but generally safe treatment for peptic ulcers and GERD, is now being tested as a probable cure for COVID-19. It's [...]

(GlobeNewswire) - Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; 'Cyclacel' or the 'Company') a biopharmaceutical company developing innovative medicines today announced that it entered into an agreement with the University [...]

BERKELEY HEIGHTS, Apr 20, 2020 (GLOBE NEWSWIRE via COMTEX) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; 'Cyclacel' or the 'Company') a biopharmaceutical company developing innovative medicines today announced that [...]

AHPPC notes that there is currently very limited evidence to support the use of medications for the treatment of COVID-19. Several medications have been proposed as likely candidates to treat [...]

(GLOBE NEWSWIRE via COMTEX) -- Sanofi finalizes Praluent(R) (alirocumab) restructuring with Regeneron Paris - April 6, 2020 - Sanofi has finalized the planned restructuring related to Praluent(R) (alirocumab) with Regeneron [...]

A Phase II/III trial to investigate Kevzara (sarilumab) has been initiated in Italy, Spain, Germany, France, Japan, Canada and Russia and is enrolling patients immediately. Regeneron Pharmaceuticals and Sanofi, which [...]

TARRYTOWN: Regeneron Pharmaceuticals, Inc. has issued the following press release: Phase 2/3 trial initiated in Italy, Spain, Germany, France, Japan, Canada and Russia and is enrolling patients immediately Kevzara inhibits [...]

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced the first patient outside of the U.S. has been treated as part of a global clinical program evaluating Kevzara (sarilumab) in [...]

ROCKVILLE, MD -- The following information was released by the Regulatory Affairs Professionals Society: By Jeff Craven As COVID-19 continues to spread around the globe, researchers and manufacturers are moving [...]

Byline: Tony Owusu To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: https://www.thestreet.com/investing/regeneron-sanofi-conduct-first-coronavirus-drug-trial-outside-us Regeneron (REGN) and Sanofi (SNY) said they'd treated the first [...]

ROCKVILLE, MD -- The following information was released by the Regulatory Affairs Professionals Society: By Zachary Brennan Opening the door to the wider use of unapproved but potential COVID-19 treatments, [...]

UC Davis Health has two clinical trials underway for hospitalized patients with severe COVID-19, the disease caused by the novel coronavirus, SARS-CoV-2. The studies are evaluating the safety and effectiveness [...]

UC Davis Health has two clinical trials underway for hospitalized patients with severe COVID-19, the disease caused by the novel coronavirus, SARS-CoV-2. The studies are evaluating the safety and effectiveness [...]

UC Davis Health has two clinical trials underway for hospitalized patients with severe COVID-19, the disease caused by the novel coronavirus, SARS-CoV-2. The studies are evaluating the safety and effectiveness [...]

Friday the first hospital in Oklahoma will begin clinical research trials for a possible COVID-19 treatment drug. The drug used in the trial is called Sarilumab, which is normally used [...]

The FDA has fast-tracked the use of convalescent plasma to treat critical coronavirus patients, and are working quickly toward convalescent plasma clinical trials from multiple investigators. The treatment has only [...]

WASHINGTON -- The following information was released by the Department of Health and Human Services: FDA issues emergency use authorization for donated hydroxychloroquine sulfate, chloroquine phosphate The U.S. Department of [...]

As research efforts to find drugs effective against COVID-19 gather pace, a public-private partnership has been set up to tackle another big problem getting drugs or vaccines safely and securely [...]

One of the largest companies developing a drug to treat the novel coronavirus, for which it received an orphan drug designation from the Food and Drug Administration, is now asking [...]

Roche has announced that the US Food and Drug Administration (FDA) has formally approved its phase 3 trial of Actemra in severely ill COVID-19 patients, who have been hospitalised with [...]

Northwell Healths Feinstein Institutes for Medical Research has announced the recruitment of patients in three clinical studies, which are designed to eliminate the COVID-19 novel coronavirus. Feinstein Institutes researchers have [...]

The U.S. Food and Drug Administration has announced it is continuing to work with the public and private sectors to ensure the availability of life-saving drugs. Innovators are looking at [...]

The U.S. Food and Drug Administration continues to play a critical role in the multifaceted all-of-government response to the COVID-19 pandemic. The efforts of FDA include facilitating medical countermeasures to [...]

Genentech, a Member of the Roche Group, said today it is launching a Phase III trial to assess its marketed arthritis drug Actemra (tocilizumab) as a treatment for adults with [...]